Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Luminex-Coupled EliFACS: A Multiparametric Method to Enumerate and Functionally Characterize Antigen-Specific T cells in Human Peripheral Blood.

Lv H, Raddassi K, Lipes MA.

Methods Mol Biol. 2019;1899:197-210. doi: 10.1007/978-1-4939-8938-6_14.

PMID:
30649774
2.

Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.

Sousa GR, Pober D, Galderisi A, Lv H, Yu L, Pereira AC, Doria A, Kosiborod M, Lipes MA.

Circulation. 2019 Feb 5;139(6):730-743. doi: 10.1161/CIRCULATIONAHA.118.036068.

PMID:
30586738
3.

Cardiac autoimmunity as a novel biomarker, mediator, and therapeutic target of heart disease in type 1 diabetes.

Lipes MA, Galderisi A.

Curr Diab Rep. 2015 May;15(5):30. doi: 10.1007/s11892-015-0598-1. Review.

4.

Role of impaired central tolerance to α-myosin in inflammatory heart disease.

Lv H, Lipes MA.

Trends Cardiovasc Med. 2012 Jul;22(5):113-7. doi: 10.1016/j.tcm.2012.07.005. Epub 2012 Aug 16. Review.

5.

Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes.

Gottumukkala RV, Lv H, Cornivelli L, Wagers AJ, Kwong RY, Bronson R, Stewart GC, Schulze PC, Chutkow W, Wolpert HA, Lee RT, Lipes MA.

Sci Transl Med. 2012 Jun 13;4(138):138ra80. doi: 10.1126/scitranslmed.3003551.

6.

Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans.

Lv H, Havari E, Pinto S, Gottumukkala RV, Cornivelli L, Raddassi K, Matsui T, Rosenzweig A, Bronson RT, Smith R, Fletcher AL, Turley SJ, Wucherpfennig K, Kyewski B, Lipes MA.

J Clin Invest. 2011 Apr;121(4):1561-73. doi: 10.1172/JCI44583. Epub 2011 Mar 23.

7.

Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure.

Stewart GC, Lopez-Molina J, Gottumukkala RV, Rosner GF, Anello MS, Hecht JL, Winters GL, Padera RF, Baughman KL, Lipes MA.

Circ Heart Fail. 2011 Jan;4(1):71-8. doi: 10.1161/CIRCHEARTFAILURE.110.958249. Epub 2010 Nov 19.

8.
9.

Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes.

Jaeckel E, Lipes MA, von Boehmer H.

Nat Immunol. 2004 Oct;5(10):1028-35. Epub 2004 Sep 19. Erratum in: Nat Immunol. 2004 Nov;5(11):1190. Nat Immunol. 2005 Feb;6(2):219.

PMID:
15378058
10.

Expression of the B7.1 costimulatory molecule on pancreatic beta cells abrogates the requirement for CD4 T cells in the development of type 1 diabetes.

Havari E, Lennon-Dumenil AM, Klein L, Neely D, Taylor JA, McInerney MF, Wucherpfennig KW, Lipes MA.

J Immunol. 2004 Jul 15;173(2):787-96.

11.

A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8.

Taylor JA, Havari E, McInerney MF, Bronson R, Wucherpfennig KW, Lipes MA.

J Immunol. 2004 Feb 15;172(4):2651-8.

12.

Metabolic decompensation in pump users due to lispro insulin precipitation.

Wolpert HA, Faradji RN, Bonner-Weir S, Lipes MA.

BMJ. 2002 May 25;324(7348):1253. No abstract available.

13.

MRI of insulitis in autoimmune diabetes.

Moore A, Sun PZ, Cory D, Högemann D, Weissleder R, Lipes MA.

Magn Reson Med. 2002 Apr;47(4):751-8.

14.

Glucose-induced toxicity in insulin-producing pituitary cells that coexpress GLUT2 and glucokinase. Implications for metabolic engineering.

Faradji RN, Havari E, Chen Q, Gray J, Tornheim K, Corkey BE, Mulligan RC, Lipes MA.

J Biol Chem. 2001 Sep 28;276(39):36695-702. Epub 2001 Jul 6.

15.

LMP2 expression and proteasome activity in NOD mice.

Kessler BM, Lennon-Duménil AM, Shinohara ML, Lipes MA, Ploegh HL.

Nat Med. 2000 Oct;6(10):1064; author reply 1065-6. No abstract available.

PMID:
11017111
16.

Overexpression of core 2 N-acetylglycosaminyltransferase enhances cytokine actions and induces hypertrophic myocardium in transgenic mice.

Koya D, Dennis JW, Warren CE, Takahara N, Schoen FJ, Nishio Y, Nakajima T, Lipes MA, King GL.

FASEB J. 1999 Dec;13(15):2329-37.

PMID:
10593880
17.
18.

Insulin-secreting non-islet cells are resistant to autoimmune destruction.

Lipes MA, Cooper EM, Skelly R, Rhodes CJ, Boschetti E, Weir GC, Davalli AM.

Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8595-600.

19.

4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice.

Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn CR.

J Biol Chem. 1995 Oct 20;270(42):24670-3.

20.

Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

Araki E, Lipes MA, Patti ME, Brüning JC, Haag B 3rd, Johnson RS, Kahn CR.

Nature. 1994 Nov 10;372(6502):186-90.

PMID:
7526222
21.

Response.

Lipes MA, Rosenzweig A, Tan KN, Tanigawa G, Seidman JG, Eisenbarth GS.

Science. 1993 Dec 3;262(5139):1584. No abstract available.

PMID:
17829386
22.
23.

Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors.

Lipes MA, Rosenzweig A, Tan KN, Tanigawa G, Ladd D, Seidman JG, Eisenbarth GS.

Science. 1993 Feb 19;259(5098):1165-9.

PMID:
8267690
24.

Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes.

Castaño L, Russo E, Zhou L, Lipes MA, Eisenbarth GS.

J Clin Endocrinol Metab. 1991 Dec;73(6):1197-201.

PMID:
1955501
25.

Transgenic mouse models of type I diabetes.

Lipes MA, Eisenbarth GS.

Diabetes. 1990 Aug;39(8):879-84. Review.

PMID:
2197138
26.

Identification, cloning, and characterization of an immune activation gene.

Lipes MA, Napolitano M, Jeang KT, Chang NT, Leonard WJ.

Proc Natl Acad Sci U S A. 1988 Dec;85(24):9704-8.

Supplemental Content

Loading ...
Support Center